They have revenues and 5 FDA approved tests. Will obtain any needed financing on their improved results and outlook. Increasing margins, Increasing sales, decreasing cost. Not a fair comparison here imo. I expect they can get all the financing they need now through non-diluting means which will be positive for shareholders. They have more to leverage now than ever before.
News 
Market Data 
Discover 
AI
